Mikael Jondal

14.4k total citations · 4 hit papers
199 papers, 12.2k citations indexed

About

Mikael Jondal is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Mikael Jondal has authored 199 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Immunology, 48 papers in Molecular Biology and 28 papers in Genetics. Recurrent topics in Mikael Jondal's work include Immune Cell Function and Interaction (83 papers), T-cell and B-cell Immunology (58 papers) and Immunotherapy and Immune Responses (30 papers). Mikael Jondal is often cited by papers focused on Immune Cell Function and Interaction (83 papers), T-cell and B-cell Immunology (58 papers) and Immunotherapy and Immune Responses (30 papers). Mikael Jondal collaborates with scholars based in Sweden, United States and France. Mikael Jondal's co-authors include Hans Wigzell, G. Holm, David J. McConkey, George Klein, Sten Orrenius, Hugh F. Pross, Sam Okret, Erik Svedmyr, Sek C. Chow and Måns Ullberg and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Mikael Jondal

199 papers receiving 10.8k citations

Hit Papers

SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES 1972 2026 1990 2008 1972 1973 1972 1974 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTES
    1972 2.1k citations Mikael Jondal, Hans Wigzell et al. The Journal of Experimental Medicine profile →
  2. SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES
    1973 428 citations Mikael Jondal, George Klein The Journal of Experimental Medicine profile →
  3. LYMPHOPENIA AND CHANGE IN DISTRIBUTION OF HUMAN B AND T LYMPHOCYTES IN PERIPHERAL BLOOD INDUCED BY IRRADIATION FOR MAMMARY CARCINOMA
    1972 390 citations Farkas Vánky, Mikael Jondal et al. profile →
  4. Continuous Lymphoid Cell Lines with Characteristics of B Cells (Bone-Marrow-Derived), Lacking the Epstein-Barr Virus Genome and Derived from Three Human Lymphomas
    1974 288 citations George Klein, Mikael Jondal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Jondal Sweden 55 6.4k 3.2k 2.8k 1.6k 1.3k 199 12.2k
Ernest C. Borden United States 66 6.0k 0.9× 4.9k 1.6× 5.8k 2.1× 1.4k 0.9× 1.2k 0.9× 311 16.2k
Alfons Billiau Belgium 66 6.7k 1.0× 3.3k 1.0× 3.3k 1.2× 1.5k 0.9× 681 0.5× 267 13.4k
Keith B. Elkon United States 70 10.1k 1.6× 4.7k 1.5× 1.3k 0.5× 1.4k 0.9× 936 0.7× 203 16.4k
Francis W. Ruscetti United States 55 11.0k 1.7× 4.6k 1.5× 2.3k 0.8× 1.0k 0.6× 585 0.5× 144 17.0k
Argyrios N. Theofilopoulos United States 71 12.2k 1.9× 3.4k 1.1× 2.3k 0.8× 1.5k 0.9× 1.1k 0.8× 219 18.2k
Chikao Morimoto United States 74 8.4k 1.3× 5.1k 1.6× 5.6k 2.0× 1.4k 0.9× 952 0.7× 339 18.5k
Kazuo Sugamura Japan 78 12.2k 1.9× 4.9k 1.5× 4.0k 1.4× 1.4k 0.8× 584 0.5× 304 20.8k
B Perussia United States 63 10.5k 1.6× 3.0k 1.0× 2.5k 0.9× 1.3k 0.8× 478 0.4× 132 14.3k
Michael A. Palladino United States 63 7.8k 1.2× 7.4k 2.3× 3.5k 1.3× 1.6k 1.0× 807 0.6× 218 18.4k
Takehiko Sasazuki Japan 71 8.2k 1.3× 5.8k 1.8× 2.9k 1.0× 1.4k 0.9× 1.4k 1.1× 351 18.7k

Countries citing papers authored by Mikael Jondal

Since Specialization
Citations

This map shows the geographic impact of Mikael Jondal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Jondal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Jondal more than expected).

Fields of papers citing papers by Mikael Jondal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Jondal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Jondal. The network helps show where Mikael Jondal may publish in the future.

Co-authorship network of co-authors of Mikael Jondal

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Jondal. A scholar is included among the top collaborators of Mikael Jondal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Jondal. Mikael Jondal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jondal, Mikael, et al.. (2009). TLR9 Activation Increases TAP‐Independent Vesicular MHC Class I Processing In vivo. Scandinavian Journal of Immunology. 70(5). 431–438. 4 indexed citations
2.
Qiao, Shengjun, Liying Chen, Sam Okret, & Mikael Jondal. (2008). Age-related synthesis of glucocorticoids in thymocytes. Experimental Cell Research. 314(16). 3027–3035. 44 indexed citations
3.
Chen, Liying, Jonas Sundbäck, Sigvard Olofsson, & Mikael Jondal. (2006). Interference with O‐glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor. International Journal of Cancer. 119(6). 1495–1500. 4 indexed citations
4.
Osorio, Lyda M., et al.. (1995). Evidence for Protein Tyrosine Kinase Involvement in CD6-Induced T Cell Proliferation. Cellular Immunology. 166(1). 44–52. 19 indexed citations
5.
Aguilar‐Santelises, Miguel, Håkan Mellstedt, & Mikael Jondal. (1994). Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.. PubMed. 8(7). 1146–52. 19 indexed citations
6.
Zhou, Xianzheng, Peter Berglund, Gary Rhodes, et al.. (1994). Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine. 12(16). 1510–1514. 155 indexed citations
7.
Jondal, Mikael, Sam Okret, & David J. McConkey. (1993). Killing of immature CD4+CD8+ thymocytes in vivo by anti‐CD3 or 5′‐(N‐ethyl)‐carboxamido‐adenosine is blocked by glucocorticoid receptor antagonist RU‐486. European Journal of Immunology. 23(6). 1246–1250. 67 indexed citations
8.
Zhou, Xianzheng, et al.. (1992). In vivo primary induction of virus-specific CTL by immunization with 9-mer synthetic peptides. Journal of Immunological Methods. 153(1-2). 193–200. 49 indexed citations
9.
Jeddi‐Tehrani, Mahmood, Sek C. Chow, Ignacio J. Ansotegui, Mikael Jondal, & Hans Wigzell. (1992). Potentiation of transmembrane signaling by cross-linking of antibodies against the β chain of the T cell antigen receptor of JURKAT T cells. Cellular Immunology. 141(1). 1–9. 3 indexed citations
10.
Duarte, Carlos A., Jorma Hinkula, Per-Anders Broliden, et al.. (1991). Monoclonal Antibodies to Conserved Regions of the Major Core Protein ( gag 24) of HIV-1 and HIV-2. AIDS Research and Human Retroviruses. 7(1). 97–101. 10 indexed citations
11.
Aguilar‐Santelises, Miguel, S.B. Svenson, Annika Loftenius, et al.. (1991). Expression of interleukin-1 alpha, interleukin-1 beta and interleukin-6 in chronic B lymphocytic leukaemia (B-CLL) cells from patients at different stages of disease progression.. PubMed Central. 84(3). 422–8. 29 indexed citations
12.
Ljunggren, K, Viviana Moschese, P A Broliden, et al.. (1990). Antibodies Mediating Cellular Cytotoxicity and Neutralization Correlate with a Better Clinical Stage in Children Born to Human Immunodeficiency Virus-Infected Mothers. The Journal of Infectious Diseases. 161(2). 198–202. 102 indexed citations
13.
Ljunggren, K, Francesca Chiodi, Gunnel Biberfeld, et al.. (1988). Lack of cross-reaction in antibody-dependent cellular cytotoxicity between human immunodeficiency virus (HIV) and HIV-related West African strains.. The Journal of Immunology. 140(2). 602–605. 19 indexed citations
14.
Ljunggren, K, Eva-Maria Fenyö, Gunnel Biberfeld, & Mikael Jondal. (1987). Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. Journal of Immunological Methods. 104(1-2). 7–14. 26 indexed citations
15.
Landegren, Ulf, Urban Ramstedt, I. AXBERG, et al.. (1982). Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.. The Journal of Experimental Medicine. 155(5). 1579–1584. 150 indexed citations
16.
Ullberg, Måns & Mikael Jondal. (1981). Recycling and target binding capacity of human natural killer cells.. The Journal of Experimental Medicine. 153(3). 615–628. 169 indexed citations
17.
Svedmyr, Erik, Mikael Jondal, Werner Henle, et al.. (1978). EBV specific killer T cells and serologic responses after onset of infectious mononucleosis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 1(3). 225–32. 11 indexed citations
18.
Klein, E., Erik Svedmyr, Mikael Jondal, & Farkas Vánky. (1977). Functional studies on tumor-infiltrating lymphocytes in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(7). 747–52. 10 indexed citations
19.
Pross, Hugh F., Malcolm G. Baines, & Mikael Jondal. (1977). Spontaneous human lymphocyte‐mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?. International Journal of Cancer. 20(3). 353–358. 31 indexed citations
20.
Kiessling, Rolf, et al.. (1976). Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.. The Journal of Experimental Medicine. 143(4). 772–780. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernest C. Borden Breakdown of academic impact, for papers by Alfons Billiau Breakdown of academic impact, for papers by Keith B. Elkon Breakdown of academic impact, for papers by Francis W. Ruscetti Breakdown of academic impact, for papers by Argyrios N. Theofilopoulos Breakdown of academic impact, for papers by Chikao Morimoto Breakdown of academic impact, for papers by Kazuo Sugamura Breakdown of academic impact, for papers by B Perussia Breakdown of academic impact, for papers by Michael A. Palladino Breakdown of academic impact, for papers by Takehiko Sasazuki
Rankless by CCL
2026